TRACON Pharmaceuticals, Inc. (TCON) Social Stream
TRACON PHARMACEUTICALS INC (TCON) Price Targets From Analysts
Use the tables below to see what analysts covering TRACON PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 2 | $14 | $10 | $11.5 | $0.175 | 6471.43% |
| 2022-03-16 | 3 | $14 | $10 | $11.5 | $0.175 | 6471.43% |
| 2022-04-08 | 4 | $14 | $8 | $11 | $0.175 | 6185.71% |
| 2022-05-12 | 3 | $12 | $8 | $10 | $0.175 | 5614.29% |
| 2022-11-15 | 3 | $12 | $8 | $9.666 | $0.175 | 5423.43% |
| 2022-12-15 | 3 | $12 | $8 | $9.25 | $0.175 | 5185.71% |
| 2023-03-09 | 2 | $12 | $8 | $9.333 | $0.175 | 5233.14% |
| 2023-04-25 | 1 | $12 | $8 | $10 | $0.175 | 5614.29% |
| 2023-05-11 | 2 | $12 | $8 | $10 | $0.175 | 5614.29% |
| 2023-06-02 | 2 | $12 | $3 | $7.666 | $0.175 | 4280.57% |
| 2023-08-15 | 3 | $12 | $3 | $6 | $0.175 | 3328.57% |
| 2023-09-08 | 3 | $12 | $1 | $5.333 | $0.175 | 2947.43% |
| 2023-11-10 | 3 | $7 | $1 | $3.666 | $0.175 | 1994.86% |
The Trend in the Analyst Price Target
TCON's average price target has moved down $6.33 over the prior 18 months.
TCON reports an average of 1,156.57% for its upside potential over the past 35 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-09 | 1 | 12 | 8 | 10.000 | 1.320 | 657.58% |
| 2023-05-11 | 2 | 12 | 8 | 10.000 | 0.666 | 1401.5% |
| 2023-06-02 | 2 | 12 | 3 | 7.666 | 0.618 | 1140.45% |
| 2023-06-02 | 3 | 12 | 3 | 7.333 | 0.618 | 1086.57% |
| 2023-11-10 | 3 | 7 | 1 | 3.666 | 0.230 | 1493.91% |
TCON Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 52 weeks, TCON's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- TCON has a higher upside potential (average analyst target price relative to current price) than 1494% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, TRACON PHARMACEUTICALS INC's number of analysts covering the stock is greater than 97.06% of them.
- TCON has a higher average analyst price target than 225.83% of Healthcare stocks.
- In terms of how TRACON PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -583.67% of that group.
In the Pharmaceutical Products industry, FENC, IKT, and TCRX are the three stocks most similar to TRACON PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding TCON using the data that counts. Try POWR Ratings for free.